The recently discovered protein NUDT5 is now presented as a candidate target for development of breast cancer treatment after being demonstrated to stop breast tumor cell growth in laboratory experiments. The research was led by Thomas Helleday (Karolinska Institute/SciLifeLab) and the results are published in Nature Communications.
Many breast cancers use hormones, such as oestrogen, to drive their growth and current treatment options aim to block the hormonal activity in order to halt the growth of the breast cancer cells. An occurring problem, however, is that tumor cells can become resistant to these treatments and develop new ways of propagating.
The current study shows that NUDT5 is operates in the nucleus of hormone-driven breast cancer cells, to produce energy for the expression of genes important for cancer growth. To explore this as a new way to starve cancer cells from their molecular energy source, the researchers developed a molecule able to block NUDT5 activity. They demonstrated that this new molecule can stop the growth of breast cancer cells in laboratory experiments.
Read the full paper
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.